TREA

88956376

Follow

Information

  • Trademark
  • 88956376
  • Serial Number
    88956376
  • Filing Date
    June 09, 2020
    4 years ago
  • Transaction Date
    September 20, 2024
    6 months ago
  • Status Date
    March 04, 2024
    a year ago
  • Published for Opposition Date
    December 08, 2020
    4 years ago
  • Location Date
    August 10, 2023
    a year ago
  • Status Code
    606
  • Current Location
    INTENT TO USE SECTION
    Employee Name
    SALES, HEATHER
  • Attorney Docket Number
    230042.215
    Attorney Name
    Jared M. Barrett
    Law Office Assigned Location Code
    N40
  • Owners
Information
Mark Drawing Code
2
Case File Statements
  • DM0000: The mark consists of a representation of an abstracted antibody on a circular background.
  • GS0051: therapeutic preparations, namely, therapeutic preparations for the treatment of HIV, cancer, graft-versus-host disease, autoimmune diseases, nonalcoholic steatohepatitis, immune system related diseases and disorders, respiratory diseases and disorders, COVID-19, and therapeutic preparations for the prevention of HIV, cancer, graft-versus-host disease, autoimmune diseases, nonalcoholic steatohepatitis, immune system related diseases and disorders, respiratory diseases and disorders, COVID-19; therapeutic preparations, namely, antibodies for use in targeting the CCR5 cell receptor
  • GS0441: providing health and medical information, and providing health and medical information in the nature of providing a website featuring information in the field of therapeutic agents, preparations and substances for the prevention and/or treatment of HIV, cancer, graft-versus-host disease, autoimmune diseases, nonalcoholic steatohepatitis, immune system related diseases and disorders, respiratory diseases and disorders, COVID-19; providing a website featuring medical information; providing a website featuring medical information in the field of antibodies for use in targeting the CCR5 cell receptor; medical analysis services, namely, medical analysis services in the field of antibodies for use in targeting the CCR5 cell receptor, and medical analysis services in the field of therapeutic agents, preparations and substances for the prevention and/or treatment of HIV, cancer, graft-versus-host disease, autoimmune diseases, nonalcoholic steatohepatitis, immune system related diseases and disorders, respiratory diseases and disorders, COVID-19
  • GS0421: scientific research consulting services, namely, scientific research consulting services in the field of immunology, and scientific research consulting services in the field of therapeutic agents, preparations and substances for the prevention and/or treatment of HIV, cancer, graft-versus-host disease, autoimmune diseases, nonalcoholic steatohepatitis, immune system related diseases and disorders, respiratory diseases and disorders, COVID-19; medical research services, and medical research services in the field of therapeutic agents, preparations and substances for the prevention and/or treatment of HIV, cancer, graft-versus-host disease, autoimmune diseases, nonalcoholic steatohepatitis, immune system related diseases and disorders, respiratory diseases and disorders, COVID-19; medical research services in the field of antibodies for use in targeting the CCR5 cell receptor
Case File Event Statements
  • 6/12/2020 - 4 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP
  • 7/6/2020 - 4 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 7/7/2020 - 4 years ago
    3 - NOTICE OF DESIGN SEARCH CODE E-MAILED Type: MDSC
  • 10/28/2020 - 4 years ago
    4 - ASSIGNED TO EXAMINER Type: DOCK
  • 11/4/2020 - 4 years ago
    5 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 11/18/2020 - 4 years ago
    6 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 12/8/2020 - 4 years ago
    7 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 12/8/2020 - 4 years ago
    8 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 2/2/2021 - 4 years ago
    9 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM
  • 7/13/2021 - 3 years ago
    10 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 7/13/2021 - 3 years ago
    11 - SOU EXTENSION 1 FILED Type: EXT1
  • 7/13/2021 - 3 years ago
    12 - SOU EXTENSION 1 GRANTED Type: EX1G
  • 7/15/2021 - 3 years ago
    13 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 1/28/2022 - 3 years ago
    14 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 1/28/2022 - 3 years ago
    15 - SOU EXTENSION 2 FILED Type: EXT2
  • 1/28/2022 - 3 years ago
    16 - SOU EXTENSION 2 GRANTED Type: EX2G
  • 2/1/2022 - 3 years ago
    17 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 6/24/2022 - 2 years ago
    18 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 6/24/2022 - 2 years ago
    19 - SOU EXTENSION 3 FILED Type: EXT3
  • 6/24/2022 - 2 years ago
    20 - SOU EXTENSION 3 GRANTED Type: EX3G
  • 6/28/2022 - 2 years ago
    21 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 1/11/2023 - 2 years ago
    22 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 1/11/2023 - 2 years ago
    23 - SOU EXTENSION 4 FILED Type: EXT4
  • 1/11/2023 - 2 years ago
    24 - SOU EXTENSION 4 GRANTED Type: EX4G
  • 1/13/2023 - 2 years ago
    25 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 8/2/2023 - a year ago
    26 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 8/2/2023 - a year ago
    28 - SOU EXTENSION 5 FILED Type: EXT5
  • 8/10/2023 - a year ago
    27 - CASE ASSIGNED TO INTENT TO USE PARALEGAL Type: AITU
  • 8/10/2023 - a year ago
    29 - SOU EXTENSION 5 GRANTED Type: EX5G
  • 8/11/2023 - a year ago
    30 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 3/4/2024 - a year ago
    31 - ABANDONMENT - NO USE STATEMENT FILED Type: ABN6
  • 3/4/2024 - a year ago
    32 - ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Type: MAB6